載入...
Low-Dose Busulfan Reduces Human CD34(+) Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice
Humanized animal models are central to efforts aimed at improving hematopoietic stem cell (HSC) transplantation with or without genetic modification. Human cell engraftment is feasible in immunodeficient mice; however, high HSC doses and conditioning limit broad use of xenograft models. We assessed...
Na minha lista:
| 發表在: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909187/ https://ncbi.nlm.nih.gov/pubmed/31890735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.10.017 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|